Site map
An overview of the available content on this site. Keep the pointer still over an item for a few seconds to get its description.
- Economic Evaluation of Healthcare Technologies
- Measurement and Valuation of Resources
- Measurement and Valuation of Health Outcomes
- Design and Evaluation of Healthcare Systems
- Economics of Population Health
- Ageing
- Clinical Guidelines
- All Completed Studies
- NHS and the UK Healthcare System
- All Current Studies - Clinical Trials (Economic Evaluation)
- Economics of Blood Transfusion
- Economics of Screening
- Genomic Technologies
- Methodological Developments in Economic Evaluation
- Modelling
- Other Economic Evaluation Work (not falling under any other headings)
- Estimating Costs for Economic Evaluation
- DCE Research at HERC
- Willingness to Pay
- Measurement of Capabilities
- Health Inequalities
- Patient Safety
- Radon
- Maternal and Child Health
- Mental Health
- Heart Disease
- Diabetes
- Disease Cost Studies
- Global Health
- Population Datasets
- MAPS: reporting statement for studies mapping onto preference-based outcome measures
- Coeliac Disease
- Inna Thalmann
- Barbara Kitchener
- Joel Smith
- David Jones
- Alastair Gray
- Borislava Mihaylova
- Iryna Schlackow
- James Buchanan
- Helen Dakin
- José Leal
- Ramon Luengo-Fernandez
- Laurence Roope
- Liz Stokes
- Apostolos Tsiachristas
- Sarah Wordsworth
- Jane Wolstenholme
- Filipa Landeiro
- Stavros Petrou
- Sasha Shepperd
- Judit Simon
- Yaling Yang
- Oliver Rivero-Arias
- Adrian Towse
- Paul Fenn
- Mandy Fruin
- Sophie Diarra
- Matthew Little
- Mara Violato
- Ana Gibertoni Cruz
- Mi Jun Keng
- Philip Clarke
- Liz Morrell
- Patrick Fahr
- Paolo Candio
- Koen Pouwels
- Sarah Briggs
- John Buckell
- Frauke Becker
- Rositsa Koleva-Kolarova
- Claire Williams
- Surya Singh
- Murong Yang
- James Altunkaya
- Melvin Obadha
- Ines Rombach
- Juliana Lui
- Jack Pollard
- Jack Pollard
- Symposium to mark the 60th Anniversary of the Hinchliffe Report
- HERC in the news - 2016 CMO Annual Report 'Generation Genome'
- HERC Newsletter - Issue 21 OUT NOW!
- Previous News
- How do pay rises affect inequality?
- NEW: DPhil Opportunities
- Chronic kidney disease policy model
- OUT NOW: HERC database of mapping studies version 6.0
- HERC Newsletter - Issue 22 OUT NOW!
- REGISTRATION NOW OPEN: Resource Allocation in Personalised Medicine: Evaluation, Translation & Ethics
- NEW: HERC database of health economics and genomics studies
- HERC Newsletter - Issue 23 OUT NOW!
- NDPH is five
- Campaigns about unnecessary antibiotic use and antibiotic resistance could backfire
- HERC Newsletter - Issue 24 OUT NOW!
- Congratulations to Mara Violato on being awarded the title of University Research Lecturer!
- DPhil Opportunities at HERC
- HERC announcement: Change in leadership
- HERC Newsletter - Issue 25 OUT NOW!
- Short courses in health economics: Introduction to Health Economic Evaluation - Booking now open for 2019
- Health expenditure on patients with multiple conditions
- Applied Methods of Cost-Effectiveness Analysis (3-Day) - Booking now open for July 2019!
- Ten-year outcomes of the Arterial Revascularisation Trial
- Statin therapy reduces cardiovascular disease risk in older people
- Philip Clarke, presents 'The origins of health economic evaluation' at Centre for Health Economics, University of York
- HERC Newsletter - Issue 26 OUT NOW!
- Low calorie meal replacements are a cost-effective routine treatment for obesity in the NHS
- Economics can help tackle the global challenge of antimicrobial resistance
- New update of HERC Database of Mapping Studies
- HERC Newsletter - Issue 27 OUT NOW!
- HERC at iHEA: Basel 2019 Congress
- Achieving Type 2 diabetes treatment targets would improve health and reduce healthcare costs
- HERC research in the spotlight: consider shorter courses when prescribing antibiotics
- Congratulations to Sarah Wordsworth on being appointed Professor of Health Economics and Genomics
- NEW: MSc in Precision Cancer Medicine
- Symposium reveals NHS challenges have changed little since 1959
- HERC Newsletter - Issue 29 - November 2019 OUT NOW!
- CANCELLED: Oxford Workshop: Ageing Without Living Longer
- The acceptability of using a lottery to allocate research funding: a survey of applicants
- The cost of self-harm to hospitals in England
- Exit strategy: how to lift lockdown
- HESG Virtual Plenary: 50th Anniversary of the QALY. Tuesday 19th May 2020
- HERC database of mapping studies
-
Publications Supporting Material
- Mixed treatment comparison of repeated measurements of a continuous endpoint
- The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84)
- Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score
- OPTIONS
- Review of statistical methods for analysing healthcare, resources and costs - additional material
- WHO Handbook on Indoor Radon: a public health perspective
- Mapping Modified Rankin Scale responses to EQ-5D utility values
- Supporting Material for Treatment Pathways, Resource Use, and Costs of Endovascular Coiling Versus Surgical Clipping After aSAH
- Supporting materials to the BMJ paper on the economic evaluation of the DiGEM study
- SF-12 Responses and EQ-5D Utility Values
- Supporting material for UKPDS Study No.65
- Variance-covariance matrices for ACHE mapping algorithms
- The Interactive Compendium of Health Datasets for Economists
- Decision Modelling for Health Economic Evaluation
- Handbooks in Health Economic Evaluation
- Economic Evaluation in Clinical Trials
- Applied Methods of Cost-effectiveness Analysis in Healthcare
- Applied Methods of Cost-Benefit Analysis in Health Care
- The influence of cost-effectiveness and other factors on NICE decisions
- HERC database of health economics and genomics studies
- Pharmaceutical policies in the long run: Reflections on 60th anniversary of the Hinchliffe Report
- Estimating pooled survival benefit using individual patient-level data meta-analyses in cost-effectiveness analysis of health care technologies: case and simulation study.
- Bayesian methods (model averaging and belief networks) when mapping from the Modified Rankin Scale to the EQ-5D
- Which health technologies, at what price and for whom: estimating the cost-effectiveness threshold for NICE and the NHS
- Management of low-grade dysplasia in ulcerative colitis in the UK National Health Service: the cost-effectiveness of immediate surgery versus ongoing surveillance.
- Impact of performance-based financing in a low resource setting: a decade of experience in Cambodia
- Modelling the cost of cancer: a system of equations approach to understanding inter-relationships
- Measuring uncertainty preferences for health
- Using CART to identify thresholds and hierarchies in funding decisions.
- Terrorism and Human Capital at Birth: Bomb Casualties and Birth Outcomes in Spain
- Understanding the underutilisation of evidence from economic evaluations in healthcare: a mixed methods design
- Cost-effectiveness - Lessons from the Global Response to HIV/AIDS
- Beware of Kinked Frontiers: A Systematic Review of the Choice of Comparator Strategies in Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening
- Banning alcohol sales at night and hospital admissions in Germany
- Predicting cancer patients’ quality of life: an analysis of the relationship between utility, treatment regimes and time
- Opportunity costs of healthcare beds: How to estimate them properly?
- If you don't snooze you lose. Evidence on health and weight.
- TBC
- A Brief History of Economic Evaluation.
- The determinants of GP referrals and elective hospital admissions: a practice level study.
- Valuing Non-fatal Health Risks: Monetary and Health-Utility Measures
- Cost-effectiveness modelling of the liver disease pathway.
- Prospects for the use of Mendelian Randomization in Economic Evaluation
- Dealing with missing quality of life data in clinical trials .
- Using discrete choice experiments to understand benefit-risk trade-offs
- What is the impact on alcohol purchases of increasing the price of sugary drinks?
- Incentives, Choice and Public Health Policy
- Macroeconomic Conditions and Opioid Abuse
- Missing data in randomised trials: beyond missing at random
- Are Public Hospitals Overcrowded? Evidence from Trauma and Orthopaedics in England
- Use of Rapid Reviews in Health Technology Assessment Processes – Effective or Impractical? A Review of the Irish System & Lessons for Others.
- Developing New Policies in Response to Rising Drug Prices in the U.S.
- Introducing rational healthcare prioritisation in Ghana: Methods and Challenges
- Value of Sample Information as a Tool for Clinical Trial Design
- EQ-5D-3L vs EQ-5D-5L: what are the consequences for cost-effectiveness in the UK?
- Carer and family effects in economic evaluation: an overview of recent research
- Using electronic health records in health economic modelling studies.
- Sensitivity analysis for not-at-random missing data in trial-based cost-effectiveness analysis
- Discrete Choice Experiments to Inform Programming and C-E Modelling of HIV Prevention
- Tracking Progress towards Universal Health Coverage in Kenya
- How do FDA policies impact demand for cigarettes and e-cigarettes in the US tobacco market? Predictions from discrete choice experiments
- Estimating survival: Does patient reported quality of life matter?
- Do consumers respond to “sin taxes” heterogeneously? New evidence from the tax on sugary drinks using retailer scanner data
- Multi-Criteria Decision Analysis for Comparative Value Assessment throughout the Drug Lifecycle
- Implications of non-marginal budgetary impacts in health technology assessment.
- Health Preference Research: past, present and possible future
- A Direct Regression Approach to Decomposing Socioeconomic Inequality of Health
- Oxford Health Economics Workshop 2019
- The causal effect of adiposity on hospital costs: Mendelian Randomization analysis of over 300,000 individuals from the UK Biobank
- Dynamic Consistency, Sample Selection and Attrition: A Panel Experiment on Individual Discount Rates
- Quality of Life Trajectories in Total Knee Replacement Patients: What can they tell us?
- Using whole disease modelling to evaluate all key interventions for schizophrenia
- Social Norms and Free-Riding in Influenza Vaccine Decisions: An Online Experiment
- Strategies to reduce inappropriate antibiotic use
- Forthcoming Talks (by HERC Researchers)
- Sex, risk, and preferences: Using stated preference data to model behaviour in HIV prevention.
- A personalized screening strategy for diabetic retinopathy: a cost-effectiveness perspective
- Difference-in-differences estimation when the dependent variable is ordinal.
- HESG Virtual Plenary: 50th Anniversary of the QALY
- Oxford Workshop: Ageing without living longer [CANCELLED]
- Dynamic Bayesian Markov model for health economic evaluations of interventions in infectious disease
- Rise or fall in equality? The dynamics of inequality measures
- Oxford Economics of Health Seminar Series 2020
- OXFORD HEALTH ECONOMICS SEMINAR: Skill Formation and the Trouble with Child Non-Cognitive Skill Measures
- OXFORD HEALTH ECONOMICS SEMINAR: Class Influence on Drug Consumption Among Teenagers
- Advances in decision modeling using R. Collaborating in an open source space
- TALK CANCELLED
- OXFORD HEALTH ECONOMICS SEMINAR: [CANCELLED]
- Learning healthcare systems for cost-effective precision oncology.